Article Details
Retrieved on: 2022-02-11 23:49:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Basel, 11 February 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Actemra®/RoActemra® (tocilizumab) intravenous (IV) has been ...
Article found on: www.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here